Fujirebio gains FDA nod for pancreatic cancer blood test
This article was originally published in Clinica
Executive Summary
The US FDA has given the go-ahead for Fujirebio Diagnostics to sell what it claims is the first blood test designed specifically for monitoring pancreatic cancer patients.